Elevance Health (ELV) Change in Receivables (2010 - 2026)

Elevance Health (ELV) has 17 years of Change in Receivables data on file, last reported at $1.2 billion in Q1 2026.

• Change in Receivables for Q1 2026 came in at $1.2 billion, down 63.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $526.0 million (down 85.29% YoY), and the FY2025 annual result was $2.5 billion, up 269.84% from the prior year.
• Change in Receivables climbed to $1.2 billion in Q1 2026 per ELV's latest filing, from -$756.0 million in the prior quarter.
• Over five years, Change in Receivables peaked at $3.2 billion in Q1 2025 and troughed at -$851.0 million in Q3 2024.
• A 5-year average of $509.1 million and a median of $282.0 million in 2024 frame the typical range for Change in Receivables.
• The sharpest annual moves came in 2023 and 2025: Change in Receivables soared 2575.0% in 2023, then plunged 491.71% in 2025.
• A 5-year view of Change in Receivables shows it stood at $1.8 billion in 2022, then sank by 43.5% to $1.0 billion in 2023, then sank by 81.35% to $193.0 million in 2024, then sank by 491.71% to -$756.0 million in 2025, then surged by 255.29% to $1.2 billion in 2026.
• Business Quant data shows ELV's Change in Receivables at $1.2 billion in Q1 2026, -$756.0 million in Q4 2025, and -$815.0 million in Q3 2025.